No headlines found.
No press releases found.
No news found.
Horizon Kinetics Medical ETF is an actively-managed exchange-traded fund ("ETF") that pursues its investment objective of investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks (such as American Depositary Receipts ("ADRs"), Global Depositary Receipts ("GDRs") and International Depositary Receipts "IDRs")) of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, generally, with an emphasis toward companies engaged in cancer research and drug development, such as pharmaceutical development companies, surgical and medical instrument manufacturers and developers, pharmaceutical manufacturers, and biotech and medical research companies. These companies derive at least 50% of their revenue from such activities. The Fund also may invest in other ETFs and purchase and write options for hedging purposes and/or direct investment.
Horizon Kinetics Medical ETF trades on the NASDAQ stock market under the symbol MEDX.
As of April 10, 2026, MEDX stock price declined to $33.19 with 108 million shares trading.
MEDX has a market cap of $18.09 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, MEDX traded as high as $35.46 and as low as $23.46.
MEDX has outperformed the market in the last year with a return of +39.5%, while the SPY ETF gained +30.9%. In the last 3 month period, MEDX beat the market returning -0.8%, while SPY returned -1.8%. However, in the most recent 2 weeks MEDX has underperformed the stock market by returning +3.3%, while SPY returned +7.2%.
MEDX support price is $33.23 and resistance is $34.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MEDX shares will trade within this expected range on the day.
